EUVIMEDEUVIMED entdecken
Crossref

Access to Anticancer Drug Trials for Adolescents With Cancer in the United States

Benjamin Grobman iD, David S Shulman iD, Vinayak Venkataraman iD, Neeharika Kothapalli, Steven G DuBois iD

Pediatric Blood & Cancer · 2026-10 · 73 (10)

DOI: 10.1002/1545-5017.70604 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 03.08.2026. Verfasst von Benjamin Grobman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Neoplasms, Antineoplastic Agents, Health Services Accessibility. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adolescents with cancer are generally underrepresented in clinical trials. The extent to which cancer drug clinical trials have become more age inclusive over time is not clear.

Methods

We utilized ClinicalTrials.gov to identify cancer drug trials from 2005 to 2025 in the United States. We categorized trials according to age of eligibility as those for adults only versus those that allowed adults as well as patients

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicNeoplasmsAntineoplastic AgentsHealth Services AccessibilityHumansAdolescentUnited StatesFemaleChildMalePatient Selection

Stichwörter der Autor:innen

adolescentcancerclinical triallymphomarecruitmentsarcoma

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Harvard Medical School, Boston, Massachusetts, USA.
  • Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.

ORCID-Profile: Benjamin Grobman, David S Shulman, Vinayak Venkataraman, Steven G DuBois

Zitieren

APA

Grobman, B., Shulman, D. S., Venkataraman, V., Kothapalli, N., & DuBois, S. G. (2026). Access to Anticancer Drug Trials for Adolescents With Cancer in the United States. Pediatric Blood & Cancer, 73(10). https://doi.org/10.1002/1545-5017.70604

Vancouver

Grobman B, Shulman DS, Venkataraman V, Kothapalli N, DuBois SG. Access to Anticancer Drug Trials for Adolescents With Cancer in the United States. Pediatric Blood & Cancer. 2026;73(10). doi:10.1002/1545-5017.70604

BibTeX
@article{Grobman2026,
  author = {Grobman, Benjamin and Shulman, David S and Venkataraman, Vinayak and Kothapalli, Neeharika and DuBois, Steven G},
  title = {Access to Anticancer Drug Trials for Adolescents With Cancer in the United States},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  volume = {73},
  number = {10},
  doi = {10.1002/1545-5017.70604}
}
Kostenlos starten →